Ms. Gorana Lakic reports

AURORA CANNABIS ACHIEVES AUSTRALIA'S TGA GMP CERTIFICATION, SETTING GLOBAL STANDARD FOR QUALITY AND COMPLIANCE

Aurora Cannabis Inc. has received good manufacturing practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia. Obtaining TGA's GMP certification enables the company to deliver top-tier cannabis products to Australia while confirming Aurora's dedication to exporting products fully compliant with TGA regulations and the stipulations of TGO 93 (Standard for Medical Cannabis). The licence grants approval for Aurora to broaden its product range offerings in the country, comprising dried flower, resin cartridges, pastilles and oils.

"I'm proud to announce Aurora has obtained TGA GMP certification for our world-class Canadian production facilities," said Gorana Lakic, vice-president, quality, at Aurora. "This achievement adds to the number of global certifications Aurora has received and solidifies our dedication to quality and compliance. With this significant achievement, we reaffirm our commitment to maintaining the highest standards and manufacturing practices to deliver premium medical cannabis products to our valued patients."

This landmark certification, granted on March 15, 2024, strengthens Aurora's dedication to supporting the continued growth and development of the Australian medical cannabis market, which is rapidly expanding and estimated to be worth $400-million (Australian), making it the largest medical market in the world outside of North America. As the long-standing exclusive supplier to MedReleaf Australia and its recently announced parent company, Aurora will continue to introduce innovative and differentiated products to the market.

MedReleaf Australia and Aurora remain dedicated to ensuring Australian patients can access a dependable and consistent supply of premium-quality products and providing doctors expanded options for patient care.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB and is a constituent of the S&P/TSX Composite Index.

We seek Safe Harbor.